Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Samumed Receives Orphan Drug Designation from FDA for SM04646

Tuesday, July 25, 2017

Samumed announced that the US Food and Drug Administration FDA has granted SM04646 a novel small molecule Wnt pathway inhibitor an Orphan Drug Designation ODD for IPF httpbitly2gStpOf The FDAs decision to grant an ODD to SM04646 for IPF is another important milestone in the development of SM04646..

Seattle Genetics Announces Clinical Collaboration with Genentech

Tuesday, July 25, 2017

Seattle Genetics Inc a global biotechnology company today announced a clinical collaboration agreement with Genentech a member of the Roche Group for the evaluation of its investigational antibodydrug conjugate ADC SGNLIV1A in combination with atezolizumab TECENTRIQ in patients with metastatic tripl..

STA Signs Supply Agreement with TESARO

Monday, July 24, 2017

STA Pharmaceutical Co Ltd a WuXi AppTec subsidiary and the leading openaccess capability and technology platform for small molecule pharmaceutical development and manufacturing announces it signed a supply agreement with the oncologyfocused biopharmaceutical company TESARO Inc TESARO for certain s..

Boehringer Ingelheim Breaks Ground on $217 Million Expansion of Fremont, California Manufacturing Facility

Monday, July 24, 2017

Boehringer Ingelheim announced a 217 million investment to upgrade and expand their Fremont manufacturing facility This investment will bring nearly 300 new highwage and highlyskilled positions to the City of Fremont The site was recently awarded 255 million in two separate tax credits from the stat..

Takeda and Schrödinger Announce Multi-Year, Multi-Target Research Collaboration

Friday, July 21, 2017

Takeda Pharmaceutical Company Limited and Schrdinger Inc a privatelyheld company dedicated to revolutionizing drug discovery through advanced computational methods today announced the formation of a multitarget research collaboration directed to diseases that align with Takedas core therapeutic area..

Pfizer Completes License Agreement For The Exclusive Commercialization Rights In Europe For CRESEMBA (isavuconazole)

Friday, July 21, 2017

Pfizer Inc and Basilea Pharmaceutica Ltd an international biopharmaceutical company specializing in the research and development of antiinfective and oncological medicines today announced they have completed the licensing agreement whereby Pfizer has obtained the exclusive commercialization rights i..

ModGene Pharma Announces Issuance of US Patent for Alzheimer's Disease Prevention

Thursday, July 20, 2017

ModGene Pharma LLC today announced the issuance of US Patent 9707231 entitled Compositions and Methods for Reduction of Amyloidbeta Load The claims cover the use of an imatinibrelated compound for reduction of amyloid production in Alzheimer39s disease The compound imatinib paradiaminomethylbenzene ..

Oncology Venture and Novartis Pharma Enter into Agreement

Thursday, July 20, 2017

Oncology Venture AB and Novartis Pharma AG Basel Switzerland have entered into an agreement providing Oncology Venture with an option right to execute an exclusive license to develop and commercialize an undisclosed small molecule kinase inhibitor in clinical development The molecule has been explor..

Glenmark Pharmaceuticals Enters Exclusive Agreement with Cyndea Pharma S.L.

Wednesday, July 19, 2017

Glenmark Pharmaceuticals a global pharmaceutical company announced today it has entered into a development license manufacture and commercial supply agreement with Cyndea Pharma SL granting exclusive rights to use their technology for developing generic softgelatin capsule formulations of certain ph..

Zymeworks and Daiichi Sankyo Announce Successful Achievement of a Research Milestone in Bispecific Antibody Collaboration

Wednesday, July 19, 2017

Zymeworks Inc a clinicalstage biopharmaceutical company dedicated to the discovery development and commercialization of nextgeneration bispecific and multifunctional biotherapeutics initially focused on the treatment of cancer and Daiichi Sankyo Company Limited Daiichi Sankyo today announced the suc..